A view of Mickey Mouse at the Walt Disney World theme park entrance on July 9, 2020 in Lake Buena Vista, Florida.With several Covid-19 vaccines in Phase 3 trials and preliminary data due as soon as later this month, Goldman Sachs is preparing its clients for a rebound in certain stocks and recommending tweaks to client portfolios.The first bucket includes stocks that have sold off in 2020 but should bounce back as people "'return to normal.
The third are those that should bounce back when global growth recovers. And the fourth bucket are those stocks that should fare well over the long term but remain shaky in the near term, even if a vaccine is approved. "While we take no view on when a vaccine will be approved for the virus, against this backdrop of potential catalysts ahead, we look across our US GIR coverage universe to identify a relatively short list of 19 stocks that our analysts believe could outperform once a vaccine is approved," wrote Goldman analyst Chris Hussey.
Pro what are they
Pro Really? A paywall?
Pro Ohhhhhh Goldman? You mean the same Assholes who clearly classified Tesla as the 'Worst Performing Asset of 2019?' Yeah keep that list to yourself please.
Pro Perhaps...!!!
MarijuanaOffic Pro They already stopped the vaccine process because someone got really really sick. BillGatesBioTerrorist BillGatesVaccine
Pro Instead of paying to lose money, I can just lose money on my own. Thank you.
Pro someone should tell these morons you can't vaccinate against an ADE infection LOL
Nigeria Nigeria Latest News, Nigeria Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: latimes - 🏆 11. / 82 Read more »